PCVX logo

Vaxcyte (PCVX) Working capital

annual working capital:

$1.65B+$697.19M(+73.34%)
December 31, 2024

Summary

  • As of today (July 3, 2025), PCVX annual working capital is $1.65 billion, with the most recent change of +$697.19 million (+73.34%) on December 31, 2024.
  • During the last 3 years, PCVX annual working capital has risen by +$1.42 billion (+623.89%).
  • PCVX annual working capital is now at all-time high.

Performance

PCVX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXbalance sheet metrics

quarterly working capital:

$1.62B-$28.24M(-1.71%)
March 31, 2025

Summary

  • As of today (July 3, 2025), PCVX quarterly working capital is $1.62 billion, with the most recent change of -$28.24 million (-1.71%) on March 31, 2025.
  • Over the past year, PCVX quarterly working capital has increased by +$189.60 million (+13.26%).
  • PCVX quarterly working capital is now -22.51% below its all-time high of $2.09 billion, reached on September 30, 2024.

Performance

PCVX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

PCVX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+73.3%+13.3%
3 y3 years+623.9%+414.2%
5 y5 years+3152.0%+1108.0%

PCVX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+623.9%-22.5%+390.1%
5 y5-yearat high+3152.0%-22.5%+611.5%
alltimeall timeat high+3152.0%-22.5%+3096.2%

PCVX Working capital History

DateAnnualQuarterly
Mar 2025
-
$1.62B(-1.7%)
Dec 2024
$1.65B(+73.3%)
$1.65B(-21.2%)
Sep 2024
-
$2.09B(+49.4%)
Jun 2024
-
$1.40B(-2.2%)
Mar 2024
-
$1.43B(+50.4%)
Dec 2023
$950.62M(+5.4%)
$950.62M(-21.4%)
Sep 2023
-
$1.21B(-3.2%)
Jun 2023
-
$1.25B(+58.7%)
Mar 2023
-
$787.93M(-12.6%)
Dec 2022
$902.03M
$902.03M(+173.0%)
Sep 2022
-
$330.45M(-0.8%)
DateAnnualQuarterly
Jun 2022
-
$333.26M(+5.8%)
Mar 2022
-
$314.97M(+38.4%)
Dec 2021
$227.63M(-33.5%)
$227.63M(-10.9%)
Sep 2021
-
$255.49M(-2.0%)
Jun 2021
-
$260.83M(-3.3%)
Mar 2021
-
$269.70M(-21.2%)
Dec 2020
$342.14M(+575.2%)
$342.14M(-5.3%)
Sep 2020
-
$361.22M(-5.0%)
Jun 2020
-
$380.16M(+183.6%)
Mar 2020
-
$134.07M(+164.6%)
Dec 2019
$50.67M(-15.5%)
$50.67M
Dec 2018
$59.95M
-

FAQ

  • What is Vaxcyte annual working capital?
  • What is the all time high annual working capital for Vaxcyte?
  • What is Vaxcyte annual working capital year-on-year change?
  • What is Vaxcyte quarterly working capital?
  • What is the all time high quarterly working capital for Vaxcyte?
  • What is Vaxcyte quarterly working capital year-on-year change?

What is Vaxcyte annual working capital?

The current annual working capital of PCVX is $1.65B

What is the all time high annual working capital for Vaxcyte?

Vaxcyte all-time high annual working capital is $1.65B

What is Vaxcyte annual working capital year-on-year change?

Over the past year, PCVX annual working capital has changed by +$697.19M (+73.34%)

What is Vaxcyte quarterly working capital?

The current quarterly working capital of PCVX is $1.62B

What is the all time high quarterly working capital for Vaxcyte?

Vaxcyte all-time high quarterly working capital is $2.09B

What is Vaxcyte quarterly working capital year-on-year change?

Over the past year, PCVX quarterly working capital has changed by +$189.60M (+13.26%)
On this page